美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA214184"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
70771-1527-5 70771-1527 HUMAN PRESCRIPTION DRUG Propafenone Hydrochloride Propafenone Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20220202 N/A ANDA ANDA214184 Zydus Lifesciences Limited PROPAFENONE HYDROCHLORIDE 425 mg/1 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1527-5)
70771-1527-6 70771-1527 HUMAN PRESCRIPTION DRUG Propafenone Hydrochloride Propafenone Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20220202 N/A ANDA ANDA214184 Zydus Lifesciences Limited PROPAFENONE HYDROCHLORIDE 425 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1527-6)
70771-1526-5 70771-1526 HUMAN PRESCRIPTION DRUG Propafenone Hydrochloride Propafenone Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20220202 N/A ANDA ANDA214184 Zydus Lifesciences Limited PROPAFENONE HYDROCHLORIDE 325 mg/1 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1526-5)
70771-1526-6 70771-1526 HUMAN PRESCRIPTION DRUG Propafenone Hydrochloride Propafenone Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20220202 N/A ANDA ANDA214184 Zydus Lifesciences Limited PROPAFENONE HYDROCHLORIDE 325 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1526-6)
68382-524-05 68382-524 HUMAN PRESCRIPTION DRUG Propafenone Hydrochloride Propafenone Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20220202 N/A ANDA ANDA214184 Zydus Pharmaceuticals (USA) Inc. PROPAFENONE HYDROCHLORIDE 425 mg/1 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-524-05)
68382-524-14 68382-524 HUMAN PRESCRIPTION DRUG Propafenone Hydrochloride Propafenone Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20220202 N/A ANDA ANDA214184 Zydus Pharmaceuticals (USA) Inc. PROPAFENONE HYDROCHLORIDE 425 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-524-14)
70771-1525-5 70771-1525 HUMAN PRESCRIPTION DRUG Propafenone Hydrochloride Propafenone Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20220202 N/A ANDA ANDA214184 Zydus Lifesciences Limited PROPAFENONE HYDROCHLORIDE 225 mg/1 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1525-5)
70771-1525-6 70771-1525 HUMAN PRESCRIPTION DRUG Propafenone Hydrochloride Propafenone Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20220202 N/A ANDA ANDA214184 Zydus Lifesciences Limited PROPAFENONE HYDROCHLORIDE 225 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1525-6)
68382-523-05 68382-523 HUMAN PRESCRIPTION DRUG Propafenone Hydrochloride Propafenone Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20220202 N/A ANDA ANDA214184 Zydus Pharmaceuticals (USA) Inc. PROPAFENONE HYDROCHLORIDE 325 mg/1 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-523-05)
68382-523-14 68382-523 HUMAN PRESCRIPTION DRUG Propafenone Hydrochloride Propafenone Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20220202 N/A ANDA ANDA214184 Zydus Pharmaceuticals (USA) Inc. PROPAFENONE HYDROCHLORIDE 325 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-523-14)
68382-522-05 68382-522 HUMAN PRESCRIPTION DRUG Propafenone Hydrochloride Propafenone Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20220202 N/A ANDA ANDA214184 Zydus Pharmaceuticals (USA) Inc. PROPAFENONE HYDROCHLORIDE 225 mg/1 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-522-05)
68382-522-14 68382-522 HUMAN PRESCRIPTION DRUG Propafenone Hydrochloride Propafenone Hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20220202 N/A ANDA ANDA214184 Zydus Pharmaceuticals (USA) Inc. PROPAFENONE HYDROCHLORIDE 225 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-522-14)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase